Care Beyond Medicine: Upholding Corporate Social Responsibility (CSR) for Patients, People, the Philippines and the Planet
08/01/2025
Latest News
Over 22,000
employees
Close to 140
countries in which the Group’s
medicines are distributed 20％
Close to 20％
of revenue from brand-name medicines
invested in R&D each year
€ 5.9 billion
euros in revenue in 2023/2024 including
€4.5 billion for brand-name medicines
and €1.4 billion for generic activities
3 therapeutic areas
Oncology, Cardiometabolism &
Venous Diseases, Neurology